MX388961B - Gotas oculares para el tratamiento de la irritacion no causada por infeccion - Google Patents
Gotas oculares para el tratamiento de la irritacion no causada por infeccionInfo
- Publication number
- MX388961B MX388961B MX2019010471A MX2019010471A MX388961B MX 388961 B MX388961 B MX 388961B MX 2019010471 A MX2019010471 A MX 2019010471A MX 2019010471 A MX2019010471 A MX 2019010471A MX 388961 B MX388961 B MX 388961B
- Authority
- MX
- Mexico
- Prior art keywords
- irritation
- treatment
- preparation
- corneal
- epithelial cells
- Prior art date
Links
- 230000007794 irritation Effects 0.000 title abstract 5
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 239000003889 eye drop Substances 0.000 title 1
- 229940012356 eye drops Drugs 0.000 title 1
- 238000002360 preparation method Methods 0.000 abstract 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- 210000002919 epithelial cell Anatomy 0.000 abstract 3
- 230000002265 prevention Effects 0.000 abstract 2
- KZMRYBLIGYQPPP-UHFFFAOYSA-M 3-[[4-[(2-chlorophenyl)-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]-n-ethylanilino]methyl]benzenesulfonate Chemical compound C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)Cl)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 KZMRYBLIGYQPPP-UHFFFAOYSA-M 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 229920006158 high molecular weight polymer Polymers 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000010186 staining Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762467139P | 2017-03-05 | 2017-03-05 | |
| PCT/IL2018/050184 WO2018163151A1 (en) | 2017-03-05 | 2018-02-19 | Eye drops for treatment of irritation not due to infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019010471A MX2019010471A (es) | 2020-02-12 |
| MX388961B true MX388961B (es) | 2025-03-20 |
Family
ID=61656085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019010471A MX388961B (es) | 2017-03-05 | 2018-02-19 | Gotas oculares para el tratamiento de la irritacion no causada por infeccion |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11033513B2 (enExample) |
| EP (2) | EP3592339B1 (enExample) |
| JP (1) | JP7258778B2 (enExample) |
| KR (1) | KR102652879B1 (enExample) |
| CN (1) | CN110891555B (enExample) |
| AU (1) | AU2018230262B2 (enExample) |
| BR (1) | BR112019018367A2 (enExample) |
| CA (1) | CA3055523C (enExample) |
| ES (1) | ES3036888T3 (enExample) |
| IL (1) | IL269133B2 (enExample) |
| MX (1) | MX388961B (enExample) |
| PL (1) | PL3592339T3 (enExample) |
| RU (1) | RU2019130955A (enExample) |
| WO (1) | WO2018163151A1 (enExample) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL80298A (en) | 1986-10-14 | 1993-01-31 | Res & Dev Co Ltd | Eye drops |
| US5895645A (en) * | 1995-01-31 | 1999-04-20 | Bausch & Lomb Incorporated | Opthalmic solution for artificial tears |
| JP3093661B2 (ja) * | 1995-10-12 | 2000-10-03 | 大塚製薬株式会社 | 眼疾患治療剤 |
| AR004214A1 (es) * | 1995-10-12 | 1998-11-04 | Otsuka Pharma Co Ltd | Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas |
| IL120005A (en) * | 1997-01-14 | 2000-08-31 | Ramot University Authority Of | Pharmaceutical compositions for the treatment of the eye |
| US5800807A (en) * | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
| IL168603A (en) * | 2005-05-16 | 2011-05-31 | Resdevco Res And Dev Co | Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells |
| DE102005055275A1 (de) | 2005-11-17 | 2007-05-24 | Ursapharm Arzneimittel Gmbh & Co. Kg | Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung |
| IL212725A (en) * | 2011-05-05 | 2016-06-30 | Resdevco Res And Dev Co | Glycerol Preparation for Non-surgical Conjunctivochalysis |
| KR102107471B1 (ko) | 2011-11-24 | 2020-05-07 | 토요 슈가 리파이닝 컴퍼니 리미티드 | 각결막 보호제 또는 각결막 장해 억제제 |
| US9278132B2 (en) | 2012-02-13 | 2016-03-08 | Bausch & Lomb Incorporated | Ophthalmic pharmaceutical compositions and methods of making and using same |
-
2018
- 2018-02-19 JP JP2019568840A patent/JP7258778B2/ja active Active
- 2018-02-19 PL PL18711415.2T patent/PL3592339T3/pl unknown
- 2018-02-19 EP EP18711415.2A patent/EP3592339B1/en active Active
- 2018-02-19 KR KR1020197029124A patent/KR102652879B1/ko active Active
- 2018-02-19 CN CN201880029944.8A patent/CN110891555B/zh active Active
- 2018-02-19 BR BR112019018367A patent/BR112019018367A2/pt not_active Application Discontinuation
- 2018-02-19 ES ES18711415T patent/ES3036888T3/es active Active
- 2018-02-19 WO PCT/IL2018/050184 patent/WO2018163151A1/en not_active Ceased
- 2018-02-19 IL IL269133A patent/IL269133B2/en unknown
- 2018-02-19 MX MX2019010471A patent/MX388961B/es unknown
- 2018-02-19 AU AU2018230262A patent/AU2018230262B2/en active Active
- 2018-02-19 RU RU2019130955A patent/RU2019130955A/ru unknown
- 2018-02-19 CA CA3055523A patent/CA3055523C/en active Active
- 2018-02-19 EP EP24173992.9A patent/EP4385565A3/en active Pending
-
2019
- 2019-09-04 US US16/560,084 patent/US11033513B2/en active Active
-
2021
- 2021-03-03 US US17/191,191 patent/US11426361B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3055523A1 (en) | 2018-09-13 |
| EP4385565A2 (en) | 2024-06-19 |
| KR20190129065A (ko) | 2019-11-19 |
| EP3592339A1 (en) | 2020-01-15 |
| JP7258778B2 (ja) | 2023-04-17 |
| US20190388361A1 (en) | 2019-12-26 |
| CN110891555A (zh) | 2020-03-17 |
| US11426361B2 (en) | 2022-08-30 |
| KR102652879B1 (ko) | 2024-03-29 |
| AU2018230262B2 (en) | 2024-01-18 |
| CA3055523C (en) | 2024-10-01 |
| EP3592339C0 (en) | 2025-04-30 |
| IL269133B1 (en) | 2024-05-01 |
| EP3592339B1 (en) | 2025-04-30 |
| EP4385565A3 (en) | 2024-08-21 |
| US20210186892A1 (en) | 2021-06-24 |
| AU2018230262A1 (en) | 2019-09-26 |
| WO2018163151A1 (en) | 2018-09-13 |
| PL3592339T3 (pl) | 2025-09-01 |
| RU2019130955A3 (enExample) | 2021-06-24 |
| BR112019018367A2 (pt) | 2020-04-07 |
| US11033513B2 (en) | 2021-06-15 |
| RU2019130955A (ru) | 2021-04-07 |
| CN110891555B (zh) | 2023-12-26 |
| JP2020509092A (ja) | 2020-03-26 |
| MX2019010471A (es) | 2020-02-12 |
| IL269133A (en) | 2019-11-28 |
| IL269133B2 (en) | 2024-09-01 |
| ES3036888T3 (en) | 2025-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011084366A3 (en) | Compositions and drug delivery systems for intraocular delivery of sirna molecules, their use for treating conditions | |
| US20170215409A1 (en) | Lamellar cornea preservation solution | |
| PH12020551766A1 (en) | Use of pilocarpine hydrochloride for the treatment of ocular conditions | |
| TW200833341A (en) | 6-aminoimidazo[1,2-b]pyridazine analogs as rho kinase inhibitors for the treatment of rho kinase-mediated diseases and conditions | |
| TW200633709A (en) | Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions | |
| WO2011053768A3 (en) | System and method for stabilizing corneal tissue after treatment | |
| EA201190219A1 (ru) | Способы и композиции для лечения ишемических состояний и состояний, связанных с функцией митохондрий | |
| Kymionis et al. | Combined transepithelial phototherapeutic keratectomy and corneal collagen crosslinking for ectatic disorders: cretan protocol | |
| PH12015502587A1 (en) | Opthalmic nanoemulsion composition containing cyclosporine and method for preparing same | |
| MY178327A (en) | Methods and biocompatible compositions to achieve sustained drug release in the eye | |
| MX2024000828A (es) | Formulaciones de parasiticida de isoxazolina y metodos para el tratamiento de la blefaritis. | |
| WO2019195761A3 (en) | Pharmacological agents for treating ocular diseases | |
| MX2021013447A (es) | Composiciones y procedimientos para el tratamiento de enfermedades oculares. | |
| AU2017261303A1 (en) | Ophthalmic compositions | |
| PH12016500869A1 (en) | Methods of treatment of ocular conditions with a sustained drug delivery implant | |
| EA201891730A1 (ru) | Офтальмологическая композиция для применения при лечении офтальмологических расстройств, связанных с изменениями роговично-конъюнктивальной поверхности | |
| KR101412776B1 (ko) | 각결막염 치료용 점안제 조성물 및 이의 제조 방법 | |
| HK1246206A1 (zh) | 用於治疗青光眼的组合物和方法 | |
| MX2020012011A (es) | Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular. | |
| MX2016006256A (es) | Tratamiento de glaucoma usando laquinimod. | |
| MX388961B (es) | Gotas oculares para el tratamiento de la irritacion no causada por infeccion | |
| NZ600040A (en) | Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and a pharmaceutical composition obtained by the method. | |
| NZ602126A (en) | Ophthalmic Solution for Treating Ocular Infection Comprising Levofloxacin or Salt Thereof or Solvate of the Same, Method for Treating Ocular Infection, Levofloxacin or Salt Thereof or Solvate of the Same, and Use Thereof | |
| WO2018230858A3 (ko) | Gly-Tβ4 (Gly-티모신β4)을 함유하는 안구건조증 치료용 약학적 조성물 | |
| ZA202405902B (en) | Low-swelling decellularized cornea, and preparation method and application thereof |